Table A8.

Serious adverse events in Study 2.

Placebo (Seven Patients, 13 Events)
Convulsion Anemia Hypotension Renal failure Decreased mobility Splenic abscess Cerebral infarction Prostate cancer Syncope Angina pectoris Chronic obstructive pulmonary disease Wound infection Hyponatremia
OnabotA 240 U (Nine Patients, 17 Events)
Bacteremia Cardiac failure congestive Chronic obstructive pulmonary disease Cellulitis Ischemic stroke Epilepsy Cognitive disorder Hypotension Decreased heart rate Pneumonia (one patient, two events) Abscess Hyperglycemia Meingocele Encephalitis Myocardial infarction Acute coronary syndrome
OnabotA 360 U (six patients, 13 events)
Appendicitis Convulsion (n = 2 patients, n = 5 events) Hypertension Chest pain Acute endocarditis Cardiac arrest Prostate cancer Gastroenteritis Dyspnea